Trace Elements, Antioxidants, Uric Acid, C-Reactive Proteins and Estrogen Levels of Preeclamptic Pregnant Women in Owerri, Nigeria
Asian Journal of Medicine and Health,
Aims: The present study investigated levels of trace elements, antioxidants, uric acid, C-reactive proteins and estrogen in preeclamptic pregnant women in Owerri, Imo State, Nigeria using patients from Federal Medical Centre (FMC) and specialists Hospital in Owerri, Nigeria.
Study Design: A total of 350 pregnant women between the ages of 20-40 years from two known hospitals in Owerri were examined for the study. The examined pregnant women were group into 160 normotensive pregnant women as control and 190 preeclamptic pregnant women.
Results and Discussion: Results obtained for serum trace elements revealed significant decrease (p<0.05) in preeclamptic pregnant women against normotensive pregnant women. Antioxidant vitamins C and E; and estrogen significantly decreased (p<0.05) in preeclamptic pregnant women against normotensive pregnant women. Uric acid and C-reactive protein levels increased in preeclamptic pregnant women against normotensive pregnant women. The decrease in trace elements could be linked to development of preeclampsia since some of these trace elements perform antioxidant function. Increased antioxidant activity and lipid peroxidation could be behind the reduced levels of vitamins C and E, and estrogen in preeclamptic pregnant women against normotensive pregnant women.
Conclusion: This study has revealed the trace elements, antioxidants, uric acid, C-reactive proteins, and estrogen levels of preeclamptic pregnant women in Owerri, Nigeria.
- trace elements.
How to Cite
Gaym A, Bailey P, Pearson L, Admasu K, Gebrehiwot Y, Team ENEA. Disease burden due to pre-eclampsia/eclampsia and the Ethiopian health system's response. International Journal of Gynecology & Obstetrics. 2011;115(1):112-116.
Aoki S, Toma R, Kurasawa K, Okuda M, Takahashi T, Hirahara F. Expectant management of severe preeclampsia with severe fetal growth restriction in the second trimester. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 2014;4 (1):81-86.
Available:http://dx.doi. org/10.1016 /j.preghy. 2013.11.006
Al-Jameil N, Tabassum, H, Al-Mayouf H, Aljohar, HI, Alenzi ND, Hijazy SM, Khan FZ. Analysis of serum trace elements-copper, manganese and zinc in preeclamptic pregnant women by inductively coupled plasma optical emission spectrometry: A prospective case controlled study in Riyadh, Saudi Arabia. Int J Clin Exp Pathol. 2014;7(5):1900-1910.
Asif N, Nagia A, Khaula K, Shahdia S. Incidence of Gestational High Blood Pressure. PJMHS. 2013;7(2):397-399.
Cunningham FG, Roberts JM, Taylor RN. Chapter 2 - The clinical spectrum of preeclampsia. In R. N. T. M. R. G. C. D. Lindheimer (Ed.), Chesley's Hypertensive Disorders in Pregnancy (Fourth Edition) San Diego: Academic Press. 2015;25-36.
Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ. 2005;330(7491):565.
Hernandez-Diaz S, Toh S, Cnattingius S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ. 2009;18:338:b2255.
Haelterman E, Qvist R, Barlow P, Alexander S. Social deprivation and poor access to care as risk factors for severe pre-eclampsia. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2003;111(1):25-32.
Haddad B, Kayem G, Deis S, Sibai BM. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol. 2007;196(237):e1–5.
Belghiti J, Kayem G, Tsatsaris V, Goffinet F, Sibai BM, Haddad B. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: The impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol. 2011;205(465): e1–6.
Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993;169(4):1000–6.
Hall DR, Odendaal HJ, Steyn DW. Expectant management of severe pre-eclampsia in the mid-trimester. Eur J Obstet Gynecol Reprod Biol. 2001;96:168–72.
Black RE. Micronutrients in pregnancy. Br.J Nutr. 2001;85-197.
Naeye R, Blane W, Paul C. Effects of maternal nutrition on human fetus. Pediatr. 1973;52:494-503.
WHO trace elements in human nutrition and health. Geneva: WHO Press. 1996;72-104.
Giles E, Doyle LW. Copper in extremely low-birth weight or very preterm infants. Am Acad Pediatr. 2007;8: 159-64.
Ziael S, Ranjkesh F, Faghihzadeh S. Evaluation of 24-hourcopper in pre-eclamptic vs normo¬tensive pregnant and nonpregnant women. Int J Fertil Steril 2008;2:9-12.
Jaiser SR, Winston GP. Copper deficiency my¬elopathy: Review. J Neurol. 2010;257:869-81.
Rumiris D, Purwosunu Y, Wibowo N, Farina A, Sekizawa A. Lower rate of preeclampsia after antioxidant supplementation in pregnant women with low antioxidant status. Hypertens Pregnancy. 2006;25:241-53.
Nino HV, Shah, W. Vitamins In: Fundamentals of Clinical Chemistry. Tietz, N.W. (ed.) 2nd edition. WB Saunders, Philadelphia. 1986;547-550.
Naidu AK. Vitamin C in human health and disease is still a mystery; an overview. Nutrition Journal. 2003;2(7):1-10.
Niki E. Free radical. Biological and Medicine. 2014;66:3-12.
Nimse BS, Pal D. Free radical, natural antioxidants and their reaction mechanism. Royal Society of Chemistry. 2015;5:27986-28006.
Mirzale F, Rahimi-Shorbaf F, Kazeroine A. Association of maternal serum C- reactive protein levels in severity of preeclampsia. Acta Medica Iranica. 2008; 4(4):293-296.
Robert JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Pwers RN. Uric acid is as important as proteinuria in identifying foetal risk in women with gestational hypertension. Hypeetension. 2005;46:1263-1269.
Bainbridge S, Robert JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008;29: 67-72.
Ikaraoha IC, Mbadiwe NC, Anetor JI, Ojareva IA. Serum trace metals in pre-eclamptic Nigerians. Asian Journal of Medical Sciences. 2015;7(3):78-83.
Fossati LP, Berti G. Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4- aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem. 1980; 26(2):227-231.
World Health Organization. A global brief on hypertension. Silent killer, global public health crisis, 2013. World Health Organization Web site.
(Accessed April 2013)
Harma M, Harma M, Kocyigit A. Correlation be¬tween maternal plasma homocysteine and zinc levels in preeclamptic women. Biol Trace Elem Res. 2005;104:97-105.
Lao TT, Chin RKH, Mark YT, Swaminath R, lam YM. Plasma and erythrocytes zinc and birth weight in pre-eclampsia pregnancies. Archives Gynoecology and Obsterics. 2010;247:167-171.
Chan S, Gerson B, Subramaniam S. The role of copper, molybdenum, selenium and zinc in nutrition and health. Clinical & Laboratory Medicine. 1998;18(4):673-685.
Acikgoz S, Harma M, Mungan G, Can M, Demirtas S. Comparison of angiotensin-converting enzyme, malonaldehyde, zinc, and copper levels in preeclampsia. Biological Trace Elements Research. 2006;113(1):1-8.
Apgar J. Zinc and reproduction. Ann Rev Nutr. 1985;5:43-68.
Chisolm JC, Handorf CR. Zinc, cadmium, metallothionein, and progesterone: do they participate in the etiology of pregnancy in-duced hypertension? Med Hypotheses. 1985;17:231-242.
Adeniyi AFF. The implication of hypozincemia in pregnancy. Acta Obstet Gynecol Scand. 1987;66:579-581.
Diaz E, Halhali A, Luna C, Diaz L, Avila E, Larrea F. Newborn birth weight correlates with placen¬tal zinc, umbilical insulin-like growth factor I and leptin levels in preeclampsia. Arch Med Res. 2002;33:40-47.
Yousef MI, El Hendy HA, El-Demerdash FM, El¬agamy EI. Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein elec¬trophoretic behavior in growing rats. Toxicology. 2002;175:223-234.
Tamura T, Goldenberg RL, Johnston KE, Dubard M. Material plasma and zinc concertation and pregnancy outcome. American Journal of clinical Nutritional. 2000;71:109-113.
Malek-mellouli M, Amara FB, Loussaief W, Reziga H. Iron status in pregnant women and its changes during preeclampsia. La tunisie Medicale. 2013;91(10):577-582.
Tasneem Z, Zafar I. Iron stataus in preeclampsia. Professional Med J. 2008;15(1):74-80.
Kandi S, Sudhakar T, Ramadevi C, Venugopal B, Rajkumar Rafi M, Ramana KV. Pre-eclampsia and iron status: A review. American Journal of Medical and Biological Research. 2014;2(6):121-123.
Rayman MP, Barlis J, Evans RW, Redman CW, King LJ. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J.Obstet Gynecol. 2002;187(2):412-418.
Rafeeinia A, Tabandeh A, Khajeniazi S, Marjani AJ. Serum Copper, Zinc and Lipid Peroxidation in Pregnant Women with Preeclampsia in Gorgan. The Open Biochemistry Journal. 2014;8:83-88.
Fang YZ, Yang S, Wu G. Free radicals, antioxidants and nutrition. Nutrition. 2002;18:872-879.
Ilhan N, Ilhan N, Simsek M. The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia. Clin. Biochem. 2002;35:393-397.
Kanagal DV, Aparna R, Kavyar R, Harish S, Prasanna KS, Harshinid U. Zinc and copper levels in preeclampsia: a study from coastal South India. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2014;3(2):370-373.
Akinloye O, Oyewale OJ, Oguntibejum OO. Evaluation of trace elements in pregnant women with pre-eclampsia. African Journal of Biotechnology. 2010;9(32):5196-5202.
Ugwu EI, Ejikeme BN, Ugwu NC, Obeka NC, Emmanuel IA, Onyechi O. Comparison of plasma copper, iron and zinc levels in hypertensive and non-hypertensive pregnant women in Abakaliki, South Eastern, Nigeria. Pakistan Journal of Nutrition. 2010;9(12):1136-1140.
Ohad K, Tal OP, Lazer T, Tamir BA, Mazor M, Witnitzer A, Sheiner E. Severe preeclampsia is associated with abnormal trace elements con¬centrations in maternal and foetal blood. Am J Obstet Gynecol. 2009;201:280-281.
Kashinakunti SV, Sunitha H, Gurupadappa K, Shankarprasad DS, Suryaprakash G, Ingin J.B. Lipid peroxidation and antioxidant status in preeclampsia. Al Ameen J Med Sci. 2010;3(1):38-41.
Mehmet H, Muge H, Ozcan E. Measurement of total antioxidant response in pre-eclampsia with a novel automated method. Eur J Obstet Gynecol & Reprod Biol. 2005;118(1):47-51.
Kiondo P, Welishe G, Wandabwa J, Wamuyu-Maina G, Bimenya GS, Okong P. African Health Sciences. 2011;11(4):566-572.
Chappell LC, Seed PT, Briley A, Kelly SRN, Frank J, Hunt BJ, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002; 187(1):127-136.
Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase and glutathione peroxidase in normal and pre-eclamptic placenta. J Soc Gynecol Investig. 1996;3:179-184.
Rokeya B. Lipid peroxidation and antioxidant status in preeclampsia. Journal of Enam medical College. 2011;1(20):56-59.
Redman CW, Beilin LJ, Bonnar J, Wilkinson RH. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet. 1976;1:1370–1373.
Chesley LC. Diagnosis of preeclampsia. Obstet Gynecol. 1985;65:423–425.
James MR, Lisa MB, Kristine YL, Carl AH, Nina M, Roberta BN, Robert WP. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension. 2005;46:1263-1269.
Lam C, Lim KH, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol. 2005; 25(1):56-60.
Bainbridge SA, Robert JM. Uric acid as a pathogenic factor in preeclampsia. Placenta. 2008; Suppl A:S67-72.
Markus GM. C-reactive protein and its role in preeclampsia. Hypertension. 2015;65:285-286.
Parchim NF, Wang W, Iriyama T, Ashimi OA, Siddiqui AH, Blackwell S, Sibai B, Kellems RE, Xia Y. Neurokinin 3 receptor and phosphocholine transferase: missing factors for pathogenesis of C-reactive protein in preeclampsia. Hypertension. 2015;65:430–439.
Berkane N, Liere P, Oudinet JP, Hertig A, Lefèvre G, Pluchino N, Schumacher M, Chabbert-Buffet N. From pregnancy to preeclampsia: Akey role for estrogens. Endocr Rev. 2017;38(2):123-144.
Abstract View: 1057 times
PDF Download: 603 times